ADR120S, Inc. (TYO:3750)
Japan · Delayed Price · Currency is JPY 882.00
0.00 (0.00%)
At close: Mar 6, 2026
ADR120S Market Cap
ADR120S has a market cap or net worth of 7.87 billion as of March 6, 2026. Its market cap has decreased by -1.23% in one year.
Market Cap
7.87B
Enterprise Value
8.03B
Revenue
40.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
882.00
Market Cap Chart
Since June 28, 2006, ADR120S's market cap has decreased from 8.22B to 7.87B, a decrease of -4.19%. That is a compound annual growth rate of -0.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 7.87B | 5.00% |
| Dec 30, 2025 | 7.50B | -2.89% |
| Dec 30, 2024 | 7.72B | -24.06% |
| Dec 29, 2023 | 10.17B | -6.18% |
| Dec 30, 2022 | 10.84B | -4.64% |
| Dec 30, 2021 | 11.37B | -10.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| StemCell Institute | 8.62B |
| BrightPath Biotherapeutics | 8.30B |
| MEDINET | 8.00B |
| CellSource | 7.57B |
| OncoTherapy Science | 7.53B |
| PRISM BioLab Co.,LTD | 7.46B |
| Chiome Bioscience | 7.22B |
| Linical | 7.00B |